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Abstract—Stanford Biodesign launched its Innovation Fel-
lowship in 2001 as a ﬁrst-of-its kind postgraduate training
experience for teaching biomedical technology innovators a
need-driven process for developing medical technologies and
delivering them to patients. Since then, many design-oriented
educational programs have been initiated, yet the impact of
this type of training remains poorly understood. This study
measures the career focus, leadership trajectory, and pro-
ductivity of 114 Biodesign Innovation Fellowship alumni
based on survey data and public career information. It also
compares alumni on certain publicly available metrics to
ﬁnalists interviewed but not selected. Overall, 60% of alumni
are employed in health technology in contrast to 35% of
ﬁnalists interviewed but not selected. On leadership, 72% of
alumni hold managerial or higher positions compared to
48% of the ﬁnalist group. A total of 67% of alumni reported
that the fellowship had been ‘‘extremely beneﬁcial’’ on their
careers. As a measure of technology translation, more than
440,000 patients have been reached with technologies devel-
oped directly out of the Biodesign Innovation Fellowship,
with another 1,000,000+ aided by solutions initiated by
alumni after their training. This study suggests a positive
impact of the fellowship program on the career focus,
leadership, and productivity of its alumni.
Keywords—Innovation, Biomedical engineering, Biomedical
technology, Health technology, Innovation Fellowship,
Biodesign.
INTRODUCTION
The Program in Biodesign was launched in 2001 at
Stanford University with a mission to help train the
next generation of leaders in biomedical technology
innovation. Its ﬁrst educational oﬀering was the
Biodesign Innovation Fellowship—a 10.5 month, full-
time training experience designed to teach aspiring
biomedical technology innovators a rigorous, need-
driven process for developing new medical devices and
preparing to deliver them into patient care. Over
15 years, Stanford Biodesign’s deﬁnition of biomedical
technology innovation has expanded beyond tradi-
tional medical devices to include device-based diag-
nostics, digital health solutions, and health
information technologies. In parallel, its educational
oﬀerings have grown to include a portfolio of graduate
and undergraduate courses, an executive education
program, international fellowships, a fellowship for
Stanford faculty, and a program to train faculty
members from universities around the world. All of
these initiatives focus on teaching a stepwise, need-
driven approach developed at Stanford, called the
biodesign innovation process.1,7 At its core, this pro-
cess involves three key phases: (1) identifying and
screening important unmet healthcare needs; (2)
inventing and vetting new technologies to address
them; and (3) developing detailed implementation
plans to bring the products to market. Some Stanford
Biodesign courses provide training on the end-to-end
process, while others tackle speciﬁc aspects in more
depth (e.g., regulatory and clinical trials, healthcare
economics, and global considerations).
The cornerstone of the overall program remains the
Biodesign Innovation Fellowship. Each year, fellows
are selected through a competitive screening process
from applicants with experience in medicine, engi-
neering, and/or business functions ranging from design
to marketing to operations. These candidates are
postgraduates: engineers typically have completed a
Master’s or PhD degree, physicians have usually ﬁn-
ished their residency or a medical fellowship, and some
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candidates have multiple degrees. Of the 100+ appli-
cants that Stanford Biodesign screens annually,
approximately 24 ﬁnalists are invited for two-days of
intensive in-person interviews. From this group, 12
individuals are selected for the program based on their
education, evidence of creativity or inventiveness in
their training or early careers, and perceived ability to
contribute to a multidisciplinary team. Teams of four
fellows each are then assembled with the goal of mix-
ing backgrounds and skill sets. The scope of the fel-
lowship has increased over time to its current size of
three teams per year.
Each academic year, a diﬀerent clinical area is
chosen as the focus, and faculty and community clin-
icians in that ﬁeld are recruited to support the training
and mentoring of the fellows.4,6 The training program
begins with a ‘‘boot camp,’’ during which the fellows
concentrate on three primary areas of learning: (1)
lectures from experts in the chosen clinical area; (2)
didactic instruction on the fundamental activities in the
biodesign innovation process that span needs ﬁnding
through concept screening; (3) execution of a ‘‘mini-
project’’ to gain ﬁrst-hand experience in applying what
they are learning about these activities. Following boot
camp, the fellows repeat the fundamental steps in the
biodesign innovation process on projects in the chosen
clinical area for the remainder of the fellowship year.
They begin with one month of immersion in clinical
practice to identify unmet healthcare needs based on
direct observations. Typically, each team generates
more than 200 needs during this period. These needs
are then researched and screened through an approach
that focuses on numerous variables including market
size, patient impact, pathophysiology, competitive
landscape, and the opportunity to create value for
healthcare stakeholders. Ultimately, needs with the
greatest potential for innovation rise to the top of the
list for further investigation. At this point, a full 3–
4 months into the training experience, the fellows be-
gin brainstorming solutions. They generate multiple
concepts for each of their top needs using a variety of
ideation techniques. Next, they screen these concepts
against factors such as technical feasibility, intellectual
property, regulatory and reimbursement pathways,
and potential business models to identify and evaluate
key risks. The concepts with the best comparative risk
proﬁle are taken forward into development and
implementation planning. This portion of the fellow-
ship depends heavily on mentorship from real-world
health technology innovators and executives to help
improve the translational potential of the projects and
ensure that the learning experience is practical.
Beyond Stanford, numerous multi-disciplinary
programs have been developed in the US and world-
wide using similar needs-driven design approaches to
health technology innovation.2 While in some cases
these programs have published the descriptions of
technologies invented by the trainees, no rigorous
study has been undertaken to understand the impact of
health technology innovation training on careers of the
alumni.3,5 Stanford Biodesign described the outcomes
of its program in terms of start-up companies founded,
funds raised, jobs created, and patients reached in an
interim report in this journal.1 However, that work did
not address the impact of the program on the subse-
quent careers of its trainees. This new study examines
the career focus, leadership, and productivity of
Stanford Biodesign alumni, as well as qualitative per-
ceptions of the program’s effectiveness. As a part of
this analysis, career metrics of the Biodesign Innova-
tion Fellowship alumni were compared to those of
ﬁnalists who ultimately were not selected for the pro-
gram. While this is clearly an imperfect comparison in
important respects, the intent was to explore any large
differences in the career trajectories of these two
groups that might lead to a better understanding of
candidate selection and/or impacts of the training
program.
METHODS
This study was a retrospective review performed
under a Stanford Institutional Review Board (IRB)
waiver that determined that the survey of fellowship
alumni did not meet federal deﬁnitions of research or
clinical investigation. Data were collected from three
sources: (1) publically available career information, (2)
a survey of Biodesign Innovation Fellowship alumni,
and (3) a survey of Biodesign trainees who have
launched companies out of the program. Data from all
three sources were gathered for alumni of the Biode-
sign Innovation Fellowship who completed the pro-
gram between June 2002 and June 2015 (n = 114).
Additionally, publically available career information
was collected for ﬁnalists (n = 120) who interviewed
for the Stanford fellowship but were not selected to
participate in the program for the years in which the
names of these ﬁnalists were available. Importantly,
the individuals performing the data collection from
public sources could not be blinded to the differences
between alumni and ﬁnalists because of their famil-
iarity with at least some of the names of the fellowship
alumni. Additional data collection details for each
source are outlined below.
Career Information from Public Data Sources
Current job titles and company names were col-
lected from public sources for the entire cohort of
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Biodesign Innovation Fellows to determine the types of
career paths that alumni have taken. Similar data were
collected from public sources for ﬁnalists who inter-
viewed for the Biodesign Innovation Fellowship but
ultimately were not selected for the program in the
application year or any subsequent application years (the
names of these candidates were available only for the
academic years ending in 2005 through 2008, and 2010
through 2015). LinkedIn (http://www.linkedin.com) was
the most commonly used source. Other web searches
were used to gather supplemental information (e.g., from
biographies on company or university websites). Specif-
ically for alumni, when no public data were available for
an individual, a personal email was sent to determine
their current role and company. Additionally, gender and
academic degrees completed before the fellowship were
collected from public sources and checked against origi-
nal fellowship application materials when available. An
alumni representative from each fellowship year then re-
examined collected data on fellowship alumni for accu-
racy.
Based on their primary role, each subject was as-
signed into diﬀerent categories for career type, func-
tional role, and type of leadership. For career type,
individuals were considered to be working in health
technology if their role was related to medical devices,
device-based diagnostics, digital health solutions, and/
or health information technology. Job titles were used
to assign each alumnus to a functional role (e.g.,
general management, R&D/engineering/design, clini-
cal/regulatory/quality, marketing/sales, business
development, operations/ﬁnance, continued academic
training, academic faculty, clinical practice, or other).
General management included top-level positions that
did not ﬁt within a speciﬁc functional area including
CEOs, principals, and presidents. Job titles were also
used to assign individuals into leadership categories
(e.g., executive oﬃcer, vice president, director, man-
ager, or individual contributor). In certain cases,
assumptions were made to standardize across position
titles (e.g., a principal at a small consulting ﬁrm was
put in the executive oﬃcer category). The individual
contributor category included individuals whose pri-
mary job title did not ﬁt into any other leadership
category (e.g., staﬀ engineer, consultant). Organiza-
tions where individuals are employed were similarly
placed into categories based on size of organization,
type of organization, and type of health technology (if
applicable). Type of health technology was only as-
signed for smaller organizations with one or a few
products. The categories included devices, device-
based diagnostics, and digital health. Health infor-
mation technology solutions were considered part of
the digital health category.
Fellowship Alumni Online Survey
In an eﬀort to capture information that is not
available through public sources, the authors devel-
oped a 33-question online survey to administer to
alumni of the Biodesign Innovation Fellowship. The
instrument was tested for face validity by a group of
selected fellowship alumni. In the survey, health tech-
nology was deﬁned the same as in the public data
collection approach. Leadership was self-determined in
one of three categories for an individual’s current
primary role: (1) leadership position with full-time di-
rect reports; (2) leadership position without full-time
direct reports, or (3) individual contributor.
For questions regarding companies founded by
Biodesign Innovation Fellowship alumni, qualifying
entities were required to have raised at least $250,000
in external grant and/or private capital funding, se-
cured their intellectual property from Stanford or
other relevant owner, and completed incorporation.
For companies founded based on work initiated after
the completion of the fellowship (rather than based on
work initiated during their training), alumni were
asked to quantify total funding raised and patients
reached to date. These data were collected in ranges,
and the lowest value in each range was used for cal-
culating a total across all alumni.
Alumni were also asked a series of qualitative
questions, including their opinions about how beneﬁ-
cial the fellowship program had been on their careers,
how well it achieved speciﬁc educational goals, how
eﬀective it was in teaching select skills, and the extent
to which it had positively aﬀected their career trajec-
tories. For all such questions, a scale of 1–5 was used
with 5 being the highest response and 1 being the
lowest.
Three emails were sent between February and
March 2016 to all Biodesign Innovation Fellowship
alumni requesting their participation in the survey. The
survey was created in and disseminated through the
Qualtrics platform (Qualtrics, Provo, UT).
Targeted Survey of Company Founders
An additional survey of 12 questions was adminis-
tered in March 2016 to Biodesign trainees (including
Biodesign Innovation Fellowship alumni) who foun-
ded companies based on work initiated during their
training with Stanford Biodesign. The same qualifying
requirements for these companies were used as in the
larger fellowship alumni survey. With regard to funds
raised and patients reached, these trainees were asked
to provide a speciﬁc total for each company (rather
than a range) and these values were summed to
determine the collective total. Participants for this
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survey were identiﬁed based on prior knowledge, as
well as results from the fellowship alumni survey. This
company tracking survey was created in and dissemi-
nated through the Qualtrics platform (Qualtrics, Pro-
vo, UT).
Two-tailed z-tests comparing population propor-
tions were used to determine a statistical difference. A
p value of less than 0.05 was considered signiﬁcant.
RESULTS
Public career data were compiled for all 114
Biodesign Innovation Fellowship alumni graduating
the program between 2002 and 2015 (100%) and for all
120 ﬁnalists who interviewed for the fellowship but
were not selected for the program from the years 2005–
2008 and 2010–2015, which were the years for which
ﬁnalist names were available. The survey of fellowship
alumni was answered by 95% of fellowship alumni
(n = 108). The targeted survey of company founders
was answered by 100% of relevant individuals
(n = 41).
Individuals completing the Biodesign Innovation
Fellowship have diverse educational backgrounds.
They include 44 MDs representing more than 20 spe-
cialties, 63 engineers (BS, MS, PhD) across a variety of
disciplines, and 7 others with graduate degrees in
business or public health and/or doctoral degrees in the
sciences. Collectively, 27 of these individuals have had
multiple degrees of relevance (e.g., MD/Engineering,
MD/MBA, Engineering/MBA). The educational
backgrounds between alumni and ﬁnalists for the fel-
lowship were notably diﬀerent, with more clinicians
accepted into the program and more PhDs interviewed
but not accepted (Table 1).
Career Focus
As determined from public data, a total of 94%
(n = 107) of all Biodesign Innovation Fellowship
alumni (n = 114) work in either clinical medicine or
health technology, with another 4% (n = 5) in biotech
or pharma. Of the 32% (n = 37) in clinical medicine,
65% (n = 24) work as faculty members or are in
continued training at an academic medical center.
Fellowship alumni hold diverse functional roles in
general management, R&D/engineering/design, clini-
cal/regulatory/quality, marketing/sales, business
development, operations/ﬁnance, continued academic
training, academic faculty, clinical practice, and other
(Fig. 1).
Further evaluation of just those Biodesign Innova-
tion Fellowship alumni actively working within the
health technology sector (61%, n = 70) reveals that
80% (n = 56) work at health technology companies;
the rest work in health technology inside a variety of
organization types, including advisory ﬁrms (incuba-
tors, consulting, and law) (9%, n = 6), biotechnology
or technology companies with health technology divi-
sions (4%, n = 3), universities with health technology-
TABLE 1. Educational background and gender at the time of
application for alumni and finalists interviewed but not se-
lected for the program.










FIGURE 1. Current functional roles of Biodesign Innovation Fellowship alumni.
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related training programs (4%, n = 3), or other (3%,
n = 2).
For alumni working speciﬁcally within health tech-
nology companies (49%, n = 56), 45% of this sub-
group (n = 25) are employed by start-ups with less
than 10 employees. The rest are in established health
technology organizations as follows: 34% small (11–
100 employees, n = 19); 4% medium (101–1000
employees, n = 2), and 18% large (>1001 employees,
n = 10). Of the start-ups and small companies (that
tend to have a single product/platform focus, n = 44),
68% (n = 30) are in medical devices, 27% (n = 12) in
digital health, and 5% (n = 2) in device-based diag-
nostics.
Speciﬁcally for the subset of fellowship alumni
(n = 93) who could be matched in the same years with
ﬁnalists interviewed but not selected for the program
(n = 120), 60% (n = 56) are currently employed in the
health technology ﬁeld compared to 35% (n = 42) of
ﬁnalists. Only 1% (n = 1) of this alumni subset works
outside healthcare in contrast to 19% (n = 23) of the
ﬁnalists (Fig. 2).
Leadership
A total of 69% (n = 74) of all Biodesign Innovation
Fellowship alumni responding to the online survey
(n = 108) self-reported that they were currently in
leadership roles, and 49% (n = 53) indicated that they
had full-time direct reports, with an average of 6.2
direct reports per manager. When divided into three
cohorts by graduation year to understand if leadership
roles increased over time, alumni show signiﬁcant
growth in leadership positions as their careers pro-
gress; 59% (n = 23/39) of alumni in the most recent
cohort hold leadership positions as compared to 68%
(n = 30/44) and 84% (n = 21/25) in the older two
groups. There was a statistical difference in leadership
roles between the 2002–2006 cohort and the 2012–2015
cohort (p = 0.035).
In order to assess the leadership positions of alumni
fellows vs. ﬁnalists who were not selected for the fel-
lowship, position titles for non-clinicians were com-
pared between the alumni and ﬁnalist groups for the
years when records of the ﬁnalist names were available.
Among alumni (n = 61), 28% (n = 17) were individual
contributors and 72% (n = 44) were managers and
above. In the control group of ﬁnalists (n = 93), 52%
(n = 48) were individual contributors and 48%
(n = 45) were managers and above (Fig. 3). There was
a statistical difference between the alumni and ﬁnalist
groups (p = 0.003).
In an eﬀort to assess the consistency of the lead-
ership information gathered from public sources vs.
the survey, we compared data from these two sources
for the alumni group (for which both sets of data
were available). In the public data approach, which
did not capture leadership roles for clinicians, 70%
(n = 54/77) of alumni were identiﬁed as managers and
above. Comparatively, in the survey, 61% (n = 44/72)
of alumni working in health technology self-identiﬁed
as managers, and 85% (n = 61/72) identiﬁed them-
selves as leaders in their roles (with or without direct
reports). Taking into account the range of the self-
reported metrics, the survey results and the data from
public sources are directionally in alignment for these
alumni, with some small potential for the overesti-
mation of management positions using the public
data approach.
Productivity
At the time of the analysis, a total of 41 companies
were formed from the combined Biodesign educational
programs, of which 61% (n = 25) were founded from
the Biodesign Innovation Fellowship (the remainder
FIGURE 2. Comparison of career type matched by year for Biodesign Innovation Fellowship alumni (left) and finalists (right)
interviewed but not selected for the fellowship.
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were from the Stanford Biodesign global fellowships
and graduate student classes). At the time the targeted
survey of company founders was completed, the
companies launched from the fellowship were respon-
sible for 460 new jobs in health technology and for
helping 440,739 patients. Beyond the fellowship, many
alumni have gone on to repeat entrepreneurial activity
in health technology, which has led to the creation of
273 additional jobs and 1,031,100 more patients helped
(Table 2). This self-reported data cannot be indepen-
dently veriﬁed, but the authors believe that it repre-
sents a reasonable estimation based on their knowledge
of the relevant companies.
Additional data were gathered regarding the current
status of the companies formed directly out of the
fellowship. Among these companies, 72% (n = 18)
remain active and an additional 20% (n = 5) have
been acquired or achieved another business exit. A
total of 88% (n = 22) of the companies are in the
medical devices space, 8% (n = 2) are in digital health,
and 4% (n = 1) are in device-based diagnostics.
Among the active companies, 36% (n = 9) are cur-
rently fully on the market, another 12% (n = 3) are
pursuing FDA ﬁlings, 16% (n = 4) are in early human
use, and 36% (n = 9) are preclinical or in clinical trials
(Fig. 4).
Another career metric addressed in the study is the
involvement of alumni in teaching or training activi-
ties. Overall, 24% (n = 27/114) of all alumni primarily
work or train in academia. Beyond that, 82% (n = 89/
108) of those completing the survey self-reported that
they have led Biodesign-related educational activities
that resulted in a combined total of more than 6000
training experiences (Table 3). (Note that ‘‘training
experiences’’ do not directly equate to a total number
of people trained since trainees may have participated
in more than one training encounter.) Each fellowship
alumnus engaged in training (n = 89) has educated an
average of 76 individuals. In the category of other
advisory responsibilities, 75% (n = 81) of fellows have
advised health technology companies, either by acting
as a consultant or subject matter expert, clinical
investigator, and/or member of a board of directors.
With respect to publications, a total of 41%
(n = 44) of alumni are listed as authors on peer-re-
viewed articles related to health technology innovation
for a total of 341 authorships. In the realm of intel-
lectual property, 72% (n = 78) of alumni are authors
on issued health technology patents for a total of 866
citations.
Eﬀectiveness of Program
All alumni participating in the survey (n = 108)
responded that the fellowship had beneﬁted their ca-
reer, with 67% (n = 72) stating that it was ‘‘extremely
beneﬁcial.’’ In a related question regarding the role of
the program in inﬂuencing career direction, 99%
FIGURE 3. Leadership positions as determined by job title for Biodesign Innovation Fellowship alumni and finalists interviewed
but not selected for the program, excluding clinicians and those in unknown roles.










Companies founded from the Biodesign Innovation Fellowship 25 460 $278,833,559 440,739
Companies founded by Biodesign Innovation
Fellowship alumni based on work after graduation
33 273 $260,416,000 1,031,100
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(n = 107) reported some inﬂuence, and 57% (n = 62)
indicated that it was ‘‘extremely inﬂuential’’ (Fig. 5).
With respect to the program’s success in achieving
speciﬁc training goals, the percentages of fellows
reporting that it was ‘‘very’’ or ‘‘extremely’’ successful
were as follows: (1) teaching a repeatable, disciplined
process for addressing unmet clinical needs (94%,
n = 101), (2) providing access to valuable network of
advisors and mentors (96%, n = 104), (3) preparing
the fellows to work effectively on multidisciplinary
teams (90%, n = 97), and (4) preparing the fellows for
leadership roles in health technology innovation (76%,
n = 82). In terms of skills acquired as a result of the
fellowship, the percentages of alumni who reported
that the program was ‘‘very’’ or ‘‘extremely’’ successful
were: (1) need ﬁnding, research, and ﬁltering (94%,
n = 102), (2) design thinking and related ideation
techniques (82%, n = 89), (3) communicating ideas
effectively to a target audience (79%, n = 85), (4)
understanding, evaluating, and prioritizing risks (78%,
n = 84), (5) strategic and business planning (68%,
n = 73), and (6) prototyping and engineering (46%,
n = 50). Alumni also self-reported the frequency with
which they have used each skill set post-fellowship,
FIGURE 4. Current status, area of focus within health technology, and stage of development for companies founded out of the
Biodesign Innovation Fellowship.
TABLE 3. Percentage of fellowship alumni who have led different types of training related to the biodesign innovation process
and the number of training experiences they have provided.
Formal training Informal training
Workshop









Fellowship alumni trainers 30% 17% 22% 72% 39%
Total training experiences 2210 1448 889 1408 830
FIGURE 5. Self-reported benefit (left) and influence (right) of the Biodesign Innovation Fellowship on alumni careers.
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with the percentage of alumni relying on them daily or
weekly as follows: (1) need ﬁnding, research, and ﬁl-
tering (34%, n = 37), (2) design thinking and related
ideation techniques (64%, n = 69), (3) communicating
ideas effectively to a target audience (66%, n = 71), (4)
understanding, evaluating, and prioritizing risks (77%,
n = 83), (5) strategic and business planning (62%,
n = 67), and (6) prototyping and engineering (36%,
n = 39).
DISCUSSION
Although a number of multidisciplinary, design-
oriented educational programs in biomedical tech-
nology innovation have been launched in universities
in the US and abroad,2 the impact of this type of
training remains difﬁcult to quantify.3,5 The present
study reports the results of a detailed survey of 114
alumni of the Stanford Biodesign Innovation Fel-
lowship, who at the time of the study were between
one and 14 years into their careers. The data indicate
that the fellowship alumni have been productive in
inventing new technologies that have translated into
patient care; they have progressed into leadership
roles in health technology; they self-report that they
value the training they received in the Biodesign
approach; and they are actively involved in mentoring
others in the this approach. This study also compares
the career metrics of the alumni with candidates who
were ﬁnalists in applying to the program but were not
selected to be fellows. Many more alumni than
ﬁnalists continue to work in the healthcare ﬁeld gen-
erally, although this could be due, at least in part, to a
much higher percentage of individuals with MDs in
the alumni group than in the ﬁnalist group. The more
striking difference is the higher proportion of fellow-
ship alumni who continue in careers in health tech-
nology innovation compared to the ﬁnalist pool. This
suggests (but, of course, does not prove) that there is
a positive impact of the program on career trajectory,
which aligns with the report of the alumni that their
training in Biodesign had a major impact on their
choice of career.
There are several important limitations to this
study. First, the comparison of the careers of individ-
uals who completed the fellowship to ﬁnalists who
were interviewed but not selected has a clear asym-
metry that could only be addressed formally by ran-
domizing the fellowship selection process. Second, the
accuracy of the data collected through publically
available sources could not be independently veriﬁed.
This is particularly true for the ﬁnalists interviewed but
not selected for the fellowship because Stanford
Biodesign does not maintain ﬁrst-hand knowledge of
these individuals beyond the application period.
Unfortunately, the program also collected limited
demographic information about these applicants dur-
ing the application process. Finally, with regard to
information collected via survey, there are limitations
intrinsic to these self-reported data, including the fact
that they, too, cannot be independently veriﬁed. For
example, the claim that alumni have created new
companies that, in aggregate, have reached over 1
million patients is based on self-reporting and cannot
be independently conﬁrmed (patient numbers are
treated as conﬁdential by the large majority of these
start-up organizations).
Overall, it is diﬃcult to determine whether an
educational program such as the Biodesign Innova-
tion Fellowship makes a signiﬁcant diﬀerence in the
career trajectories and contributions of its trainees.
One could reasonably ask if these individuals would
excel independent of the training program. Although
this study does not deﬁnitively answer this question,
it suggests that the training program is seen as having
a positive inﬂuence by its alumni. The Biodesign
alumni hold more leadership roles in health technol-
ogy than the comparison group of talented individ-
uals with similar educational backgrounds. This
diﬀerence is especially pronounced at the executive
level, perhaps due to the high rate of start-up activity
among Biodesign Innovation Fellowship alumni. The
fellowship alumni unanimously report that the
training was beneﬁcial to their careers and a high
percentage believe it was inﬂuential on their career
pathway.
The current study also conﬁrms ﬁndings from a
prior report1 that the Biodesign Innovation Fellows
are effective in inventing technologies during their
training. However, a key objective of the fellowship
is to teach a repeatable process for health technol-
ogy innovation that alumni can continue to apply in
their careers. The fact that more companies have
been started (and more patients reached) by fellow-
ship alumni based on work after their time at
Stanford Biodesign compared to during their time in
the fellowship suggests that the fellows are applying
what they have learned beyond the scope of the
program.
The survey data reﬂecting the alumni’s view of the
skills training they received during the fellowship was
particularly instructive. The alumni especially valued
their training in needs ﬁnding, research, and ﬁltering,
although they reported that they were not using these
skills regularly in their current positions. The fact that
the training in the category of prototyping and engi-
neering was clearly ranked weakest among the skills
developed provides an important opportunity for
improvement in the program.
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Reviewing data from the alumni demonstrates
additional areas where attention is required moving
forward. Most striking of these is that the, the fellow-
ship has been largely male-dominated. The program has
made some progress in this respect recently, but is ac-
tively reviewing its recruitment and communications
strategies to achieve a more equal gender balance going
forward. Clearly, another area that calls for signiﬁcant
ongoing eﬀort is reﬁning the methods of assessing the
impact of the fellowship training, potentially including
prospective methods for more detailed tracking of data
from alumni and the comparison group.
While more work needs to be done to truly under-
stand the eﬀects of the Stanford Biodesign Innovation
Fellowship, this study suggests a positive impact of the
fellowship program on the career focus, leadership,
and productivity of its alumni.
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